Acute Heart Failure Current Perspectives

Acute Heart Failure

Acute Heart Failure in the Emergency Department

Use of Biomarkers in the Emergency Department

Using Biomarker (BNP) Measurements

Other Useful Biomarkers for Diagnosis of HF

Biomarkers of AHF

Relationship Between Discharge BNP and Outcomes

PROTECT Secondary End Points: HF Hospitalization and Rehospitalization

Use of Biomarkers in AHF

Using Biomarkers Across the ARC of Heart Failure Hospitalization

Biomarkers Across the ARC of Heart Failure Hospitalizations

Using Biomarkers Across the ARC of Heart Failure Hospitalization

Decision Making in AHF

Decision Making in AHF

Efficacy and Limitations of Current AHF Therapies

Treatment of HF

Management of AHF

Vasodilators

Novel Therapies and Recent Clinical Data in the Treatment of

AHF

Therapy for AHF

Therapy for AHF

ATOMIC-AHF Omecamtiv MecarbilDyspnea Response

3 Buckets

Pre-RELAX-AHF: Rapid Dyspnea Improvement Through

24 hours (Likert Scale)

Serelaxin

RELAX-AHF

RELAX-AHF: Cardiovascular and All-Cause

Mortality

RELAX AHF: Biomarker Changes

Putting Readmissions Into Perspective

Readmissions

H2H Challenges: A Community Call-to-Action

RELAX-AHF

References

References (cont)

References (cont)

Abbreviations

Abbreviations (cont)